Diabetic Neuralgia
5
0
0
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
13 treatments under study, led by Phyllanthus Niruri
Research Leaders
7 sponsors active, led by Queen Elizabeth II Health Sciences Centre
Related Conditions
Often studied with 7 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 5 trials
100.0%
+13.4% vs benchmark
20%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 4 completed trials
Clinical Trials (5)
Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).
A Study of Phyllanthus Niruri and Sida Cordifolia in Diabetic Peripheral Polyneuropathy
Neuragen for Peripheral Diabetic Neuropathy
Safety and Efficacy Study in Subjects With Diabetic Neuropathic Pain
Treatment of Painful Diabetic Neuropathy With Photon Stimulation
Research Network
Common Treatments
- Phyllanthus Niruri1
- Abt8941
- Carisbamate1
- Sida Cordifolia Placebo1
- Phyllanthus Niruri Extract1
Active Sponsors
- Queen Elizabeth II Health Sciences Centre1
- AbbVie (prior sponsor, Abbott)1
- SK Life Science, Inc.1
- Rosenberg European Academy of Ayurveda1
- EUROPEAN PROFESSIONAL ASSOCIATION OF AYURVEDA PRACTITIONERS AND THERAPISTS1
Top Investigators
The Canadian College of Naturopathic Medicine
AbbVie
Dalhousie University
VA Northern California Health Care System; UC Davis School of Medicine
P.D. Patel Ayurveda Hospital / Rosenberg European Academy of Ayurveda
Related Conditions
- Diabetic Polyneuropathy4
- Diabetic Neuropathy Painful3
- Diabetic Mononeuropathy2
- Diabetic Neuropathies2
- Diabetic Peripheral Neuropathy1